Related Experiment Video
Updated: Jul 18, 2025
06:42
A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
Published on: April 16, 2018
16.1K
Melatonin as a potential treatment for septic cardiomyopathy
Amira Mohamed Taha1, Abdelrahman Mohamed Mahmoud2, Mohamed M Ghonaim2
1Faculty of Medicine, Fayoum University, Fayoum, Egypt; Medical Research Group of Egypt (MRGE), Negida Academy, Arlington, MA, USA.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|August 24, 2023
Summary
Melatonin shows promise for treating sepsis-induced cardiomyopathy (SCM), a serious condition with no current drug treatments. Further clinical trials are needed to confirm its effectiveness and optimal use.
Area of Science:
- Cardiology
- Pharmacology
- Endocrinology
Background:
- Septic cardiomyopathy (SCM) is a frequent and fatal complication of sepsis.
- Its development involves inflammation, mitochondrial dysfunction, oxidative stress, and immune issues.
- No effective pharmacological treatments currently exist for SCM.
Purpose of the Study:
- To review the evidence for melatonin's potential role in treating sepsis-induced cardiomyopathy.
- To explore melatonin's mechanisms of action and cardioprotective effects in the context of sepsis.
Main Methods:
- Review of experimental and preclinical studies on melatonin and SCM.
- Analysis of melatonin's antioxidant, anti-inflammatory, and anti-apoptotic properties.
- Investigation of potential synergistic effects with other therapeutic agents.
Main Results:
- Melatonin exhibits antioxidant, anti-inflammatory, anti-apoptotic, and cardioprotective effects.
- Experimental studies suggest melatonin protects against cardiovascular diseases and SCM.
- Combinations of melatonin with other drugs show enhanced therapeutic potential.
Conclusions:
- Melatonin demonstrates promising preclinical results for sepsis-induced cardiomyopathy.
- Its safety profile and natural occurrence support further clinical investigation.
- Clinical trials are essential to determine optimal melatonin dosage, administration, and efficacy for SCM.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
01:14Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
01:19Management of Insomnia
281
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
281
01:29Cardiomyopathy VI: Nursing Management
13
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
13
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11